Aging, tumor suppression and cancer: high wire-act!
暂无分享,去创建一个
[1] Mitch Leslie,et al. The age of cancer. , 2006, Science of aging knowledge environment : SAGE KE.
[2] J. Campisi,et al. Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation , 2004, Journal of Cell Science.
[3] N. Barzilai,et al. The paradox of the insulin/IGF-1 signaling pathway in longevity , 2004, Mechanisms of Ageing and Development.
[4] T. Kunkel. DNA Replication Fidelity* , 2004, Journal of Biological Chemistry.
[5] C. Harris,et al. p53: 25 years after its discovery. , 2004, Trends in pharmacological sciences.
[6] J. Campisi. Fragile fugue: p53 in aging, cancer and IGF signaling , 2004, Nature Medicine.
[7] K. Mohammad,et al. Modulation of mammalian life span by the short isoform of p53. , 2004, Genes & development.
[8] Qin M. Chen,et al. Novel mechanisms of sublethal oxidant toxicity: induction of premature senescence in human fibroblasts confers tumor promoter activity. , 2003, Experimental cell research.
[9] M. Blasco. Mammalian telomeres and telomerase: why they matter for cancer and aging. , 2003, European journal of cell biology.
[10] Masashi Narita,et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways , 2003, The EMBO journal.
[11] S. Lowe,et al. Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence , 2003, Cell.
[12] A. Melk,et al. Cell senescence in rat kidneys in vivo increases with growth and age despite lack of telomere shortening. , 2003, Kidney international.
[13] Judith Campisi,et al. Cancer and ageing: rival demons? , 2003, Nature Reviews Cancer.
[14] Joseph A. Buckwalter,et al. The Role of Chondrocyte Senescence in the Pathogenesis of Osteoarthritis and in Limiting Cartilage Repair , 2003, The Journal of bone and joint surgery. American volume.
[15] Patricia D. Castro,et al. Cellular senescence in the pathogenesis of benign prostatic hyperplasia , 2003, The Prostate.
[16] J. Hoeijmakers,et al. Aging and Genome Maintenance: Lessons from the Mouse? , 2003, Science.
[17] J. Foekens,et al. Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression , 2003, Thrombosis and Haemostasis.
[18] J. Campisi. Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes , 2003, Experimental Gerontology.
[19] Matthias Blüher,et al. Extended Longevity in Mice Lacking the Insulin Receptor in Adipose Tissue , 2003, Science.
[20] Martin Holzenberger,et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice , 2003, Nature.
[21] Goberdhan P Dimri,et al. Control of the Replicative Life Span of Human Fibroblasts by p16 and the Polycomb Protein Bmi-1 , 2003, Molecular and Cellular Biology.
[22] D. Schild,et al. Recombinational DNA repair and human disease. , 2002, Mutation research.
[23] J. Campisi,et al. Cancer and aging: a model for the cancer promoting effects of the aging stroma. , 2002, The international journal of biochemistry & cell biology.
[24] M. Radman,et al. Specialized DNA Polymerases, Cellular Survival, and the Genesis of Mutations , 2002, Science.
[25] Bret S. Weinstein,et al. The reserve-capacity hypothesis: evolutionary origins and modern implications of the trade-off between tumor-suppression and tissue-repair , 2002, Experimental Gerontology.
[26] Jan Vijg,et al. Large genome rearrangements as a primary cause of aging , 2002, Mechanisms of Ageing and Development.
[27] K. Helin,et al. The role of p53 and pRB in apoptosis and cancer. , 2002, Current opinion in genetics & development.
[28] B. Herman,et al. Ageing and apoptosis , 2002, Mechanisms of Ageing and Development.
[29] J. Campisi,et al. Telomeres, aging and cancer: In search of a happy ending , 2002, Oncogene.
[30] D. Dunson,et al. Mutational fingerprints of aging. , 2002, Nucleic acids research.
[31] Stephen N. Jones,et al. p53 mutant mice that display early ageing-associated phenotypes , 2002, Nature.
[32] Antony M. Carr,et al. The evolution of diverse biological responses to DNA damage: insights from yeast and p53 , 2001, Nature Cell Biology.
[33] J. Campisi. Cellular senescence as a tumor-suppressor mechanism. , 2001, Trends in cell biology.
[34] J. Campisi,et al. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[35] Mina J. Bissell,et al. Putting tumours in context , 2001, Nature Reviews Cancer.
[36] S. Gollapudi,et al. Functional Decline in Aging and Disease: A Role for Apoptosis , 2001, Journal of the American Geriatrics Society.
[37] V. Weaver,et al. Tumour-stromal interactions: Integrins and cell adhesions as modulators of mammary cell survival and transformation , 2001, Breast Cancer Research.
[38] T. Osler,et al. Senescence and the healing rates of venous ulcers. , 2001, Journal of vascular surgery.
[39] K. Vousden,et al. Regulation and function of the p53 tumor suppressor protein. , 2001, Current opinion in cell biology.
[40] Elise C. Kohn,et al. The microenvironment of the tumour–host interface , 2001, Nature.
[41] Goberdhan P Dimri,et al. Regulation of cellular senescence by p53. , 2001, European journal of biochemistry.
[42] V. Paradis,et al. Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. , 2001, Human pathology.
[43] M. Shekhar,et al. Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. , 2001, Cancer research.
[44] J. Shay,et al. Cellular senescence as a tumor-protection mechanism: the essential role of counting. , 2001, Current opinion in genetics & development.
[45] T. Tlsty,et al. Know thy neighbor: stromal cells can contribute oncogenic signals. , 2001, Current opinion in genetics & development.
[46] H. Dvorak,et al. Differential expression of thymosin β‐10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[47] L. Balducci,et al. Cancer and age in the USA. , 2001, Critical reviews in oncology/hematology.
[48] P. Singhal,et al. Tubular cell senescence and expression of TGF-beta1 and p21(WAF1/CIP1) in tubulointerstitial fibrosis of aging rats. , 2001, Experimental and molecular pathology.
[49] W. Hahn,et al. Genes involved in senescence and immortalization. , 2000, Current opinion in cell biology.
[50] Ronald A. DePinho,et al. The age of cancer , 2000, Nature.
[51] Steven N. Austad,et al. Why do we age? , 2000, Nature.
[52] L. Guarente,et al. Genetic pathways that regulate ageing in model organisms , 2000, Nature.
[53] M J Bissell,et al. The influence of the microenvironment on the malignant phenotype. , 2000, Molecular medicine today.
[54] M. Benson,et al. Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia. , 2000, Urology.
[55] G. Lithgow,et al. Natural selection: Evolution of lifespan in C. elegans , 2000, Nature.
[56] M. Serrano,et al. Tumor suppressors and oncogenes in cellular senescence☆ , 2000, Experimental Gerontology.
[57] G. Enders,et al. p16INK4a can initiate an autonomous senescence program , 2000, Oncogene.
[58] M. Barcellos-Hoff,et al. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. , 2000, Cancer research.
[59] R. Reddel. The role of senescence and immortalization in carcinogenesis. , 2000, Carcinogenesis.
[60] J. Gray,et al. Genome changes and gene expression in human solid tumors. , 2000, Carcinogenesis.
[61] R. DePinho,et al. A critical role for telomeres in suppressing and facilitating carcinogenesis. , 2000, Current opinion in genetics & development.
[62] R. Faragher. Cell senescence and human aging: where's the link? , 2000, Biochemical Society transactions.
[63] Goberdhan P Dimri,et al. Regulation of a Senescence Checkpoint Response by the E2F1 Transcription Factor and p14ARF Tumor Suppressor , 2000, Molecular and Cellular Biology.
[64] G. Roth,et al. Cellular proliferation potential during aging and caloric restriction in rhesus monkeys (Macaca mulatta) , 1999, Journal of cellular physiology.
[65] J. Handa,et al. Senescence-associated β-galactosidase histochemistry for the primate eye , 1999 .
[66] R. DePinho,et al. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus , 1999, Nature.
[67] C. Prives,et al. The p53 pathway , 1999, The Journal of pathology.
[68] D. Woods,et al. Senescence of human fibroblasts induced by oncogenic Raf. , 1998, Genes & development.
[69] C. Sherr,et al. Tumor surveillance via the ARF-p53 pathway. , 1998, Genes & development.
[70] G. Peters,et al. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts , 1998, Current Biology.
[71] G. Adami,et al. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts , 1998, Oncogene.
[72] D. Wynford‐Thomas,et al. Reinitiation of DNA Synthesis and Cell Division in Senescent Human Fibroblasts by Microinjection of Anti-p53 Antibodies , 1998, Molecular and Cellular Biology.
[73] M. Skobe,et al. Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[74] S. Aaronson,et al. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[75] J. Campisi,et al. Aging and Cancer: The Double‐Edged Sword of Replicative Senescence , 1997, Journal of the American Geriatrics Society.
[76] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[77] G. Martin,et al. The genetics of aging. , 2003, Annual review of genomics and human genetics.
[78] P. Enright,et al. Sleep Disturbance, Psychosocial Correlates, and Cardiovascular Disease in 5201 Older Adults: The Cardiovascular Health Study , 1997, Journal of the American Geriatrics Society.
[79] B. Howard,et al. Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent , 1996, Molecular and cellular biology.
[80] O. Pereira-smith,et al. Replicative Senescence: Implications for in Vivo Aging and Tumor Suppression , 1996, Science.
[81] J. Campisi,et al. Replicative Senescence: An Old Lives' Tale? , 1996, Cell.
[82] G. Martin. Somatic mutagenesis and antimutagenesis in aging research. , 1996, Mutation research.
[83] J. Bishop. Cancer: the rise of the genetic paradigm. , 1995, Genes & development.
[84] B. Ames,et al. Oxidative DNA damage and senescence of human diploid fibroblast cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[85] G. Wahl,et al. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. , 1994, Genes & development.
[86] R. Pignolo,et al. Replicative senescence of human fibroblast-like cells in culture. , 1993, Physiological reviews.
[87] C B Harley,et al. Telomere end-replication problem and cell aging. , 1992, Journal of molecular biology.
[88] R. Miller,et al. Gerontology as oncology. Research on aging as the key to the understanding of cancer , 1991, Cancer.
[89] R. Sager. Senescence as a mode of tumor suppression. , 1991, Environmental health perspectives.
[90] J. Shay,et al. Defining the molecular mechanisms of human cell immortalization. , 1991, Biochimica et biophysica acta.
[91] H. Gabius,et al. Detection and functions of mammalian lectins--with emphasis on membrane lectins. , 1991, Biochimica et biophysica acta.
[92] Thomas E. Johnson,et al. Evolutionary biology of aging , 1990 .
[93] L. Hayflick. THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.
[94] George C. Williams,et al. PLEIOTROPY, NATURAL SELECTION, AND THE EVOLUTION OF SENESCENCE , 1957, Science of Aging Knowledge Environment.
[95] J. Shay,et al. Telomeres and Telomerase: Implications for Cancer and Aging , 2001, Radiation research.
[96] N. Ellis,et al. DNA helicases, genomic instability, and human genetic disease. , 2000, Annual review of genomics and human genetics.
[97] A. Knudson,et al. Chasing the cancer demon. , 2000, Annual review of genetics.
[98] John Calvin Reed. Mechanisms of apoptosis avoidance in cancer. , 1999, Current opinion in oncology.
[99] J. Handa,et al. Senescence-associated beta-galactosidase histochemistry for the primate eye. , 1999, Investigative ophthalmology & visual science.
[100] A. Simpson,et al. Evolution and the inevitability of human cancer. , 1998, Seminars in cancer biology.
[101] K. Kinzler,et al. Cancer-susceptibility genes. Gatekeepers and caretakers. , 1997, Nature.
[102] W. Birchmeier,et al. Epithelial-mesenchymal transitions in development and tumor progression. , 1995, EXS.
[103] G. Cunha,et al. Stromal regulation of epithelial function. , 1991, Cancer treatment and research.
[104] R. Bosch,et al. Pathogenesis of benign prostatic hyperplasia. , 1991, European urology.
[105] Edward L. Schneider,et al. Handbook of the Biology of Aging , 1990 .
[106] J Salvage,et al. A matter of life and death. , 1981, Nursing times.
[107] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.
[108] L. Hayflick,et al. THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS 1 , 1964 .